The table below shows Day One Biopharmaceuticals, Inc.'s income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
Line item
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Revenue
$158.18M
$131.16M
$0.00
$0.00
-
-
Cost of revenue
-
-
-
-
-
-
Gross profit
-
-
-
-
-
-
R&D
$148.13M
$227.70M
$130.52M
$85.62M
$43.58M
$9.10M
SG&A
$120.59M
DAWN annual revenue (10-K history)
Day One Biopharmaceuticals, Inc. reported annual revenue of $158.18M for fiscal year 2025. That is up 20.6% from $131.16M in fiscal 2024. Figures come from the company's audited annual reports as filed with the SEC.